World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02646410
Date of registration: 29/12/2015
Prospective Registration: No
Primary sponsor: University of Bamako
Public title: Optimization of Seasonal Malaria Chemoprevention (SMC) Delivery SMC
Scientific title: Optimal Delivery of Seasonal Malaria Chemoprevention and Its Effects on the Acquisition of Malaria Immunity
Date of first enrolment: August 2014
Target sample size: 10000
Recruitment status: Unknown status
URL:  https://clinicaltrials.gov/show/NCT02646410
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Factorial Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Mali
Contacts
Name:     Alassane Dicko, MD
Address: 
Telephone:
Email: adicko@icermali.org
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

Age >= 3 months & < 60 months

Exclusion Criteria:

- severe, chronic illness

- known allergy to one of the study drugs (SP or AQ)

- known HIV positive subjects using Cotrimoxazole.



Age minimum: 3 Months
Age maximum: 59 Months
Gender: All
Health Condition(s) or Problem(s) studied
Malaria
Anemia
Intervention(s)
Other: DDD+DOT
Other: FPD+DOT
Other: FPD+NDOT
Other: DDD+NDOT
Primary Outcome(s)
Hospital admission [Time Frame: 1, 2, 3, 4 years of the intervention]
Coverage of SMC [Time Frame: 1-5 weeks after last round of SMC in Year1]
Incidence of clinical malaria in Year 2 [Time Frame: up to 4 weeks after the last round of SMC]
Mortality rate [Time Frame: 1, 2, 3, 4 years of the intervention]
Secondary Outcome(s)
moderate anemia [Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
Clinical malaria in Year 1 [Time Frame: up to 4 weeks after the last round of SMC]
nutritional status [Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
immune response to malaria parasite [Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
molecular markers of resistance to SP + AQ [Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
malaria parasitemia [Time Frame: one week before the first round of SMC and 4-6 weeks after the last round of SMC]
Secondary ID(s)
2014-61
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history